“…Mast cells also express iPLA 2 , a prototypic iPLA 2 isoform, and the iPLA 2 inhibitor bromoenol lactone (BEL) can attenuate granule exocytosis by mast cells (39), leading to the suggestion that iPLA 2  participates in the regulation of mast cell activation. Although iPLA 2  has long been thought to play a role in phospholipid remodeling (40), recent studies using mice or cells that are devoid of iPLA 2  as a result of gene targeting or siRNA knockdown have defined its roles in various signaling events, such as Ca 2ϩ release-activated Ca 2ϩ (CRAC) channel opening (41), lipid mediator generation (42,43), exocytosis (44), cytokine secretion (45), cell migration (46), vascular contractility (47), apoptosis (48,49), cancer (50), and neuronal degeneration (51,52). Because of its roles in Ca 2ϩ gating and lipid mediator generation, the sequential action of iPLA 2  and cPLA 2 ␣ for the full operation of AA release has been proposed in vascular cells (42).…”